Carly Kenselaar

Item: Carly Kenselaar
Rating: 2.88
Author: StockAnalysis.com

Stock Analyst at Citigroup

(2.88)

# 1,555

Out of 5,131 analysts

Total ratings

100%

Success rate

99.6%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$261.41	-32.67%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$34.58	-7.46%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $261.41

Upside: -32.67%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $34.58

Upside: -7.46%